On Monday, the top TSX mover was Bombardier Inc. (TSX: T.BBD.B, Stock Forum). It fell 0.2% and was trading at $4.70 on volume of 4.1 million shares.
Today the transportation equipment manufacturer published its 2012 Corporate Social Responsibility (CSR) Report and Report Summary, entitled Shaping the Future of Mobility, Responsibly, presenting the company's CSR activities over the past year.
The key achievement was being listed on both the Dow Jones Sustainability North America and World Indices, benchmark indicators of sustainability for the sixth consecutive year. Bombardier was also awarded Sector Leader, considered to be the company within its sector best prepared to seize the opportunities and manage risks derived from economic, environmental and social developments.
Air Canada (TSX: T.AC.B, Stock Forum) was the second most active stock on the TSX. The stock was down 7.4% and trading at $2.01 on volume of 3 million.
On May 9, the airliner announced the closing of a private offering of three tranches of enhanced equipment trust certificates, in the aggregate face amount of US$714.5 million. The private offering is comprised of Class A certificates, Class B certificates and Class C certificates.
The Class A certificates have an interest rate of 4.125% per annum and a final expected distribution date of May 15, 2025. The Class B certificates have an interest rate of 5.375% per annum and a final expected distribution date of May 15, 2021. The Class C certificates have an interest rate of 6.625% per annum and a final expected distribution date of May 15, 2018.
Andover Mining Corp. (TSX: V.AOX, Stock Forum) was the volume leader on the TSX Venture Exchange. It fell 5.3% and was trading at $0.18 on volume of 3.4 million.
The precious and base metals exploration and development company had no related news to explain the high volume in trading.
The second most active stock on the TSX Venture was Med BioGene Inc. (TSX: V.MBI, Stock Forum) It rallied 40% and was trading at $0.14 after 3.3 million shares changed hands.
The life science company will be holding an upcoming annual and special meeting on May 17, 2013.